◀ Back to SREBF1
SREBF1 — STAT3
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Ueki et al., Proc Natl Acad Sci U S A 2004
(Diabetes Mellitus...) :
In obese animals, increased SOCS proteins enhance SREBP-1c expression by antagonizing
STAT3 mediated inhibition of
SREBP-1c promoter activity
Farrell et al., J Hepatol 2005
:
In obese animals, increased SOCS proteins enhance SREBP-1c expression by antagonizing
STAT3 mediated inhibition of
SREBP-1c promoter activity
Ueki et al., Hepatology research : the official journal of the Japan Society of Hepatology 2005
:
This
STAT3 mediated inhibition of
SREBP-1c expression is antagonized by co-expression of SOCS proteins
Bhatnagar et al., J Biol Chem 2009
:
In contrast, FGF-19 increased the activity of
STAT3 , an
inhibitor of
SREBP-1c expression and decreased the expression of peroxisome proliferator activated receptor-gamma coactivator-1beta ( PGC-1beta ), an activator of SREBP-1c activity